Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution.
Mazzucchelli S, Signati L, Messa L, Franceschini A, Bonizzi A, Castagnoli L, Gasparini P, Consolandi C, Mangano E, Pelucchi P, Cifola I, Camboni T, Severgnini M, Villani L, Tagliaferri B, Carelli S, Pupa SM, Cereda C, Corsi F. Mazzucchelli S, et al. Among authors: signati l. Cancer Cell Int. 2024 Jun 27;24(1):220. doi: 10.1186/s12935-024-03375-5. Cancer Cell Int. 2024. PMID: 38926706 Free PMC article.
Publisher Correction: Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy.
Sevieri M, Andreata F, Mainini F, Signati L, Piccotti F, Truffi M, Bonizzi A, Sitia L, Pigliacelli C, Morasso C, Tagliaferri B, Corsi F, Mazzucchelli S. Sevieri M, et al. Among authors: signati l. J Nanobiotechnology. 2024 May 27;22(1):288. doi: 10.1186/s12951-024-02532-2. J Nanobiotechnology. 2024. PMID: 38797820 Free PMC article. No abstract available.
Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy.
Sevieri M, Andreata F, Mainini F, Signati L, Piccotti F, Truffi M, Bonizzi A, Sitia L, Pigliacelli C, Morasso C, Tagliaferri B, Corsi F, Mazzucchelli S. Sevieri M, et al. Among authors: signati l. J Nanobiotechnology. 2024 Apr 15;22(1):184. doi: 10.1186/s12951-024-02441-4. J Nanobiotechnology. 2024. PMID: 38622644 Free PMC article.
HER-2-Targeted Nanoparticles for Breast Cancer Diagnosis and Treatment.
Sitia L, Sevieri M, Signati L, Bonizzi A, Chesi A, Mainini F, Corsi F, Mazzucchelli S. Sitia L, et al. Among authors: signati l. Cancers (Basel). 2022 May 13;14(10):2424. doi: 10.3390/cancers14102424. Cancers (Basel). 2022. PMID: 35626028 Free PMC article. Review.
Ultrastructural analysis of breast cancer patient-derived organoids.
Signati L, Allevi R, Piccotti F, Albasini S, Villani L, Sevieri M, Bonizzi A, Corsi F, Mazzucchelli S. Signati L, et al. Cancer Cell Int. 2021 Aug 10;21(1):423. doi: 10.1186/s12935-021-02135-z. Cancer Cell Int. 2021. PMID: 34376194 Free PMC article.